Understand the divide and learn how to accelerate programs from discovery to GMP.

Moving from promising preclinical data to a clinically viable candidate is where many programs struggle.

Join for a session on preparing for GMP readiness and building the quality systems needed to support clinical development. Discussion will be based on the transition from lab-scale research to process development, including the analytical testing and manufacturing considerations that emerge along the way.

Those who are thinking about commercialization and want a clearer understanding of what it takes to move a drug candidate toward the clinic are encouraged to join.

Registration is required. 

For more information, please see the event flyer.

Questions?

Please contact Joice Kanefsky